Anemia, mortality, and hospitalizations in heart failure with a preserved ejection fraction (from the TOPCAT trial)

K Gupta, R Kalra, I Rajapreyar, JM Joly, M Pate… - The American journal of …, 2020 - Elsevier
In this post-hoc analysis of the TOPCAT trial, we evaluated the prognostic role of anemia in
adverse cardiovascular (CV) outcomes in heart failure with a preserved ejection fraction …
被引用次数：30 相关文章

Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial).

K Gupta, R Kalra, I Rajapreyar, JM Joly… - The American Journal …, 2020 - europepmc.org
In this post-hoc analysis of the Treatment of Preserved Cardiac Function Heart Failure with
an Aldosterone Antagonist (TOPCAT) trial, we evaluated the prognostic role of anemia in …

Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)

K Gupta, R Kalra, I Rajapreyar… - The American …, 2020 - pubmed.ncbi.nlm.nih.gov
In this post-hoc analysis of the TOPCAT trial, we evaluated the prognostic role of anemia in
adverse cardiovascular (CV) outcomes in heart failure with a preserved ejection fraction …

Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)

K Gupta, R Kalra, I Rajapreyar, JM Joly… - American Journal of …, 2020 - profiles.wustl.edu
In this post-hoc analysis of the TOPCAT trial, we evaluated the prognostic role of anemia in
adverse cardiovascular (CV) outcomes in heart failure with a preserved ejection fraction …

Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)

K Gupta, R Kalra, I Rajapreyar, JM Joly… - American Journal of …, 2020 - ajconline.org
In this post-hoc analysis of the TOPCAT trial, we evaluated the prognostic role of anemia in
adverse cardiovascular (CV) outcomes in heart failure with a preserved ejection fraction …

[引用][C] Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)

K Gupta, R Kalra, I Rajapreyar, JM Joly… - The American Journal …, 2020 - cir.nii.ac.jp
Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from
the TOPCAT Trial) | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …

Anemia, Mortality, and Hospitalizations in Heart Failure With a Preserved Ejection Fraction (from the TOPCAT Trial)

K Gupta, R Kalra, I Rajapreyar, JM Joly… - American Journal of …, 2020 - experts.umn.edu
In this post-hoc analysis of the TOPCAT trial, we evaluated the prognostic role of anemia in
adverse cardiovascular (CV) outcomes in heart failure with a preserved ejection fraction …
[HTML] nih.gov

[HTML][HTML] Anemia, Mortality, and Hospitalizations in Heart Failure with a Preserved Ejection Fraction (From The TOPCAT Trial)

K Gupta, R Kalra, I Rajapreyar, J Joly… - The American journal …, 2020 - ncbi.nlm.nih.gov
In this post-hoc analysis of the Treatment of Preserved Cardiac Function Heart Failure with
an Aldosterone Antagonist (TOPCAT) trial, we evaluated the prognostic role of anemia in …